Suppl Figure 2 from Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER
Jeff Hsu, Colin Chong, Jeffrey Serrill, Levina Goon et autres
0 citations
Jeff Hsu
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
62Publications signalées
2837Citations signalées
2Affiliations récentes
Les institutions déclarées
Les domaines associés
Phagocytosis and Immune RegulationRNA modifications and cancerChronic Lymphocytic Leukemia ResearchCancer-related molecular mechanisms researchRNA and protein synthesis mechanisms
Les publications récentes
Suppl Figure 4 from Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER
Jeff Hsu, Colin Chong, Jeffrey Serrill, Levina Goon et autres
0 citations
Supplementary Figures and Tables from Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER
Jeff Hsu, Colin Chong, Jeffrey Serrill, Levina Goon et autres
0 citations
Suppl Figure 5 from Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER
Jeff Hsu, Colin Chong, Jeffrey Serrill, Levina Goon et autres
0 citations
Suppl Figure 1 from Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER
Jeff Hsu, Colin Chong, Jeffrey Serrill, Levina Goon et autres
0 citations
Suppl Figure 3 from Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER
Jeff Hsu, Colin Chong, Jeffrey Serrill, Levina Goon et autres
0 citations
Long-Term Survival and Undetectable Circulating Tumor DNA Following Comprehensive Involved Site Radiotherapy for Oligometastases
Megha Schmalzle, Rachel Radigan, M. Krainock, M.C. Liu et autres
us (code pays fourni par la source)
0 citations
International Journal of Radiation Oncology*Biology*Physics
The Cardiovascular Care of the Pediatric Athlete
Peter N. Dean, Julie A. Brothers, Kristin M. Burns, Jonathan B. Edelson et autres
us, ch (code pays fourni par la source)
15 citations
Journal of the American College of Cardiology
Cardiac alterations related to new CT emphysema subtypes: results from the SubPopulations and InteRmediate Outcome Measures In COPD and Heart Failure Study (SPIROMICS HF)
Daniel Shepshelovich, Aparna Balasubramanian, João A.C. Lima, Martin R. Prince et autres
us, gb, ch, de (code pays fourni par la source)
0 citations
Data from Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER
Jeff Hsu, Colin Chong, Jeffrey Serrill, Levina Goon et autres
0 citations
Suppl Figure 2 from Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER
Jeff Hsu, Colin Chong, Jeffrey Serrill, Levina Goon et autres
0 citations
Supplementary Figures and Tables from Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER
Jeff Hsu, Colin Chong, Jeffrey Serrill, Levina Goon et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.